Ruxience conc perf 100 mg/10 ml, , Ruxience conc perf 100 mg/10 ml 2 flac 10 ml

7680697010037 CH-69701 L01FA01

No images available

Details

Product number
6970101
CPT
-
Packaging group
-
Unit
-

Articles (1)

Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
2 x 1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
19/08/2025
Professional SmPC
Français
19/08/2025
Professional SmPC
Italien
19/08/2025

Detailed composition

Substance Quantity Type Category
rituximabum
100.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
natrium
0.07 MG Substance HBESI
polysorbatum 80
- Substance HNIDK
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 475.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2025

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69701
Drug name
Ruxience, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FA01
Authorization status
Z
Dispensation category
A
First authorization
19/08/2024
Authorization expiration date
18/08/2029
IT number
07.16.1.
Domain
Human medicine
Field of application
Non-Hodgkin-Lymphom, Rheumatoide Arthritis, ANCA-assoziierte Vaskulitis, Pemphigus vulgaris

Packaging details

Description (FR)
RUXIENCE 100 mg/10 ml conc perf 100 mg 2x1 pce
Description (DE)
RUXIENCE 100 mg/10 ml Konz Inf 100 mg 2x1 Stk
Market launch
11/08/2025
Market withdrawal
11/08/2025
Narcotic (BTM)
No

Other packaging sizes

RUXIENCE conc perf 100 mg/10ml vial 10 ml
1 DUR
GTIN: 7680697010013
View
RUXIENCE conc perf 500 mg/50ml vial 50 ml
1 DUR
GTIN: 7680697010020
View
Buy us a coffee Explore the data